2PointZero Group has announced its participation in the Series G preferred equity financing round of Whoop, Inc. (WHOOP), a leading consumer health and wellness technology platform. The round was led by Collaborative Fund, with additional backing from a group of global investors.
Founded in 2012 and headquartered in Boston, WHOOP has established itself as a go-to platform for health-conscious consumers, professional athletes, and enterprise wellness programmes. Its subscription-based model offers continuous health monitoring, personalised coaching, and data-driven insights to a global membership spanning more than 200 countries and territories.
The investment marks a strategic step for 2PointZero Group as it expands its presence in consumer-driven sectors. By adding WHOOP to its portfolio, the Group strengthens its wellness vertical with a high-growth technology platform that aligns with its focus on businesses with strong brand equity, recurring revenue streams, and multiple growth drivers.
Samia Bouazza, CEO of 2PointZero Group, said the firm targets opportunities where scalability, strong fundamentals, and long-term growth converge. She highlighted WHOOP’s position at the intersection of technology, health, and data, noting its defensible market position, engaged community, and clear pathway to profitability.
Bouazza also emphasised the Group’s broader confidence in the consumer health technology sector, pointing to projections that the global wearables market could approach $300 billion by 2032. She noted that the investment reflects 2PointZero Group’s strategy of partnering with strong founders and management teams to drive sustained growth and long-term value creation.
Commenting on the partnership, Will Ahmed, Founder and CEO of WHOOP, said the company is entering a new phase of global expansion and is pleased to welcome 2PointZero Group as an investor. He highlighted WHOOP’s growing footprint in the UAE, where it has been active since 2017 following its early collaboration with Expo 2020 Dubai. Today, the UAE represents one of the company’s strongest international markets.
Ahmed added that the new investment will support WHOOP’s continued expansion both in the UAE and globally, as it works to transform how individuals understand and improve their health.
The company continues to innovate its product offering. In May 2025, WHOOP launched its latest 5.0 and MG wearable devices, which were recognised on TIME Magazine’s “Best Inventions of 2025” list. In addition, WHOOP has partnered with Unilabs to introduce its Advanced Labs programme in the UAE, providing members with access to a comprehensive 65-biomarker blood testing panel across the country.
